Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar skc0001 (< 20) Submitted: 10/30/2006 3:11:34 AM : Outperform Start Price: $11.91 AMRI Score: -78.68

a VALUE PROPOSITION

Featured Broker Partners


Advertisement